What question did this study set out to answer?

The aim is to explore the potential of serotonin synthesis amplification as an adjunct to serotonin reuptake inhibitors.

April 5, 2026Journal of Clinical Psychopharmacology0 citationsOpen Access

View Full Paper

Serotonin Synthesis Amplification to Augment the Therapeutic Efficacy of Serotonin Reuptake Inhibitor Antidepressants

SCStefania Chaikali JJJacob P. R. Jacobsen

Key Points

The aim is to explore the potential of serotonin synthesis amplification as an adjunct to serotonin reuptake inhibitors.
Assessment of existing serotonin reuptake inhibitors
Analysis of serotonin synthesis amplification mechanisms
Evaluation of pharmacological implications in clinical settings
No FDA-approved drug uses serotonin synthesis amplification for SRI augmentation
Potential for broader clinical application identified
Indicates the need for further exploration in treatment scenarios

Abstract

Despite this encouraging evidence, no SRI adjunctive FDA-approved drug product uses a serotonin synthesis amplification pharmacology. Such a drug could exhibit general SRI-augmentation therapeutic potential and be scalable across clinical scenarios.

问 AI

Bookmark

View Full Paper

Cite This Study

Chaikali et al. (Fri,) studied this question.

synapsesocial.com/papers/69d1fc8ea79560c99a0a2341 https://doi.org/https://doi.org/10.1097/jcp.0000000000002180

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

问 AI

Bookmark

View Full Paper